US Medication Risk Evaluation and Mitigation Strategies (REMS) FHIR IG
2.0.0 - STU 2

US Medication Risk Evaluation and Mitigation Strategies (REMS) FHIR IG - Downloaded Version 2.0.0 See the Directory of published versions

## Credits

This Implementation Guide is the result of the efforts of the CodeX REMS Integration Use Case, with the support and active participation of the following participants:

- AbbVie
- APCER
- Bristol Meyers Squibb
- InfoWerks
- Invaryant
- Lamics
- MITRE
- NCPDP
- Otsuka
- Point-of-Care Partners
- Prescryptive
- REMS Industry Consortium (RIC)
- Syneos
- UBC
- US Food and Drug Administration (FDA)

Our thanks to these organizations and to the individuals not explicitly listed who contributed their time, enthusiasm and expertise to this work.